Lauren Jacobs, CFA, is an equity analyst for DF Investments. She is evaluating Iron Parts Inc. Iron Parts is a manufacturer of interior systems and components for automobiles. The company is the world's second largest original equipment auto parts supplier, with a market capitalization of $1.8 billion. Based on Iron Parts's low price-to-book value ratio of 0.9* and low price-to-sales ratio of 0.15x, Jacobs believes the stock could be an interesting investment. However, she wants to review the disclosures found in the company's financial footnotes. In particular, Jacobs is concerned about Iron Parts's defined benefit pension plan. The following information for 2007 and 2008 is provided.Iron Parts has adopted SFAS No. 158, Employers' Accounting for Defined Benefit Pensions and Other Postretirement Plans.Jacobs wants to fully understand the impact of changing pension assumptions on Iron Parts's balance sheet and income statement. In addition, she would like to compute Iron Parts's economic pension expense.For the year ended December 31, 2008, Iron Parts's economic pension expense is closest to:
Answer(s): B
Economic pension expense can be calculated by summing the changes in the PBO for the period (excluding benefits paid) and then subtracting the actual return on assets. The change in the PBO (excluding benefits) is $147 (635 reported 2008 PBO + 22 benefits paid - 510 reported 2007 PBO). Subtract the actual return to get economic pension expense of $110 (147 change in PBO excluding benefits paid - 37 actual return).Alternatively, economic pension expense is equal to the change in the funded status for the period excluding the firm's contributions. 2008 funded status was -240 (395 plan assets -635 PBO) and the funded status for 2007 was -183 (327 plan assets - 510 PBO). Contributions were $53 (calculated in Question 81). Thus, economic pension expense is $110 (-57 change in funded status - 53 contributions). (Study Session 6, LOS 22.g)
Carl Warner, CFA, has been asked to review the financial information of Global Drug World (GDW) in preparation for a possible takeover bid by rival competitor Consolidated Drugstores International (Consolidated). GDW has produced impressive results since going public via an initial public offering in 1998. Through a program of aggressive growth by acquisition, GDW is currently seen as a major player and a threat to Consolidated^ own plans for growth and profitability. In preparation for his analysis, Warner has gathered the following financial data from GDW's year-end statements:Partial GDW Balance Sheet on May 31, 2008 As part of his analysis, Warner needs to forecast the free cash flow to the firm (FCFF) for 2009. The best information he has points to an increase in sales of 6%. The earnings before interest and tax (EBIT) margin is not expected to change from the rate of 6.4% achieved in 2008. Additional fixed capital spending is expected to be $36,470. Investment in net working capital is expected to be $24,313. Moreover, Warner notes that the only noncash charge is depreciation, which he estimates will be $60,000.Warner has been asked to analyze the effect each of the following corporate events, if taken during 2009, would have on GDW's free cash flow to equity (FCFE):• 20% increase in dividends per share.• Repurchase of 25% of the firm's outstanding shares using cash.• New common share offering that would increase shares outstanding by 30%.• New issue of convertible bonds that are not callable for fi\e years and would increase the level of debt by 10%.The 2008 free cash flow to the firm (FCFF) for Global Drug World (GDW) in dollars is closest to:
Answer(s): A
Free cash flow to the firm can be calculated in various ways. One approach to calculate FCFF is to start with net income:
Carl Warner, CFA, has been asked to review the financial information of Global Drug World (GDW) in preparation for a possible takeover bid by rival competitor Consolidated Drugstores International (Consolidated). GDW has produced impressive results since going public via an initial public offering in 1998. Through a program of aggressive growth by acquisition, GDW is currently seen as a major player and a threat to Consolidated^ own plans for growth and profitability. In preparation for his analysis, Warner has gathered the following financial data from GDW's year-end statements:Partial GDW Balance Sheet on May 31, 2008 As part of his analysis, Warner needs to forecast the free cash flow to the firm (FCFF) for 2009. The best information he has points to an increase in sales of 6%. The earnings before interest and tax (EBIT) margin is not expected to change from the rate of 6.4% achieved in 2008. Additional fixed capital spending is expected to be $36,470. Investment in net working capital is expected to be $24,313. Moreover, Warner notes that the only noncash charge is depreciation, which he estimates will be $60,000.Warner has been asked to analyze the effect each of the following corporate events, if taken during 2009, would have on GDW's free cash flow to equity (FCFE):• 20% increase in dividends per share.• Repurchase of 25% of the firm's outstanding shares using cash.• New common share offering that would increase shares outstanding by 30%.• New issue of convertible bonds that are not callable for fi\e years and would increase the level of debt by 10%.By how much (in dollars) does GDW's FCFF exceed its free cash flow to equity (FCFE) in 2008?
FCFE can be expressed in terms of FCFF as follows:FCFE = FCFF - Int(l - tax rate) + net borrowingTherefore, the amount by which FCFF exceeds FCFE can be written as: FCFF - FCFE = Int(l - tax rate) - net borrowingInt - $25,488Net borrowing = $5,866 - $33,275 = -$27,409 (additional information)Therefore: FCFF - FCFE = $25,488(1 - 0.3) - (-$27,409) = $45,251 (Study Session 12, LOS 41.e)
Carl Warner, CFA, has been asked to review the financial information of Global Drug World (GDW) in preparation for a possible takeover bid by rival competitor Consolidated Drugstores International (Consolidated). GDW has produced impressive results since going public via an initial public offering in 1998. Through a program of aggressive growth by acquisition, GDW is currently seen as a major player and a threat to Consolidated^ own plans for growth and profitability. In preparation for his analysis, Warner has gathered the following financial data from GDW's year-end statements:Partial GDW Balance Sheet on May 31, 2008 As part of his analysis, Warner needs to forecast the free cash flow to the firm (FCFF) for 2009. The best information he has points to an increase in sales of 6%. The earnings before interest and tax (EBIT) margin is not expected to change from the rate of 6.4% achieved in 2008. Additional fixed capital spending is expected to be $36,470. Investment in net working capital is expected to be $24,313. Moreover, Warner notes that the only noncash charge is depreciation, which he estimates will be $60,000.Warner has been asked to analyze the effect each of the following corporate events, if taken during 2009, would have on GDW's free cash flow to equity (FCFE):• 20% increase in dividends per share.• Repurchase of 25% of the firm's outstanding shares using cash.• New common share offering that would increase shares outstanding by 30%.• New issue of convertible bonds that are not callable for fi\e years and would increase the level of debt by 10%.The cost of equity and the sustainable growth rate (using beginning equity) are closest to:Cost of equity Sustainable growth rate
The cost of equity can be determined from the capital asset pricing model. We get:
Carl Warner, CFA, has been asked to review the financial information of Global Drug World (GDW) in preparation for a possible takeover bid by rival competitor Consolidated Drugstores International (Consolidated). GDW has produced impressive results since going public via an initial public offering in 1998. Through a program of aggressive growth by acquisition, GDW is currently seen as a major player and a threat to Consolidated^ own plans for growth and profitability. In preparation for his analysis, Warner has gathered the following financial data from GDW's year-end statements:Partial GDW Balance Sheet on May 31, 2008 As part of his analysis, Warner needs to forecast the free cash flow to the firm (FCFF) for 2009. The best information he has points to an increase in sales of 6%. The earnings before interest and tax (EBIT) margin is not expected to change from the rate of 6.4% achieved in 2008. Additional fixed capital spending is expected to be $36,470. Investment in net working capital is expected to be $24,313. Moreover, Warner notes that the only noncash charge is depreciation, which he estimates will be $60,000.Warner has been asked to analyze the effect each of the following corporate events, if taken during 2009, would have on GDW's free cash flow to equity (FCFE):• 20% increase in dividends per share.• Repurchase of 25% of the firm's outstanding shares using cash.• New common share offering that would increase shares outstanding by 30%.• New issue of convertible bonds that are not callable for fi\e years and would increase the level of debt by 10%.The 2009 estimate of FCFF is closest to:
When depreciation is the only noncash charge, FCFF can be estimated from:
Share your comments for CFA CFA-Level-II exam with other users:
i would like to take psm1 exam.
cbd and pdb are key to the database
the purchase and download process is very much streamlined. the xengine application is very nice and user-friendly but there is always room for improvement.
please upload p_sapea_2023
anyone use this? the question dont seem to follow other formats and terminology i have been studying im getting worried
good questions
hello are these questions valid for ms-102
some questions are wrongly answered but its good nonetheless
how to get system serial number using intune
is it really helpful to pass the exam
#229 in incorrect - all the customers require an annual review
kindy upload
fantastic assessment on psm 1
56 question correct answer a,b
thank you for providing the q bank
true quesstions
i can´t believe ms asks things like this, seems to be only marketing material.
hi, could you please add the last update of ns0-527
question #3 refers to vnet4 and vnet5. however, there is no vnet5 listed in the case study (testlet 2).
sometimes it may be good some times it may be
qs 4 answer seems wrong- please check
very detailed explanation !
the interactive nature of the test engine application makes the preparation process less boring.
very useful.
complete question dump should be made available for practice.
i just passed my first exam. i got 2 exam dumps as part of the 50% sale. my second exam is under work. once i write that exam i report my result. but so far i am confident.
nice create dewey stefen
i just wrote this exam and it is still valid. the questions are exactly the same but there are about 4 or 5 questions that are answered incorrectly. so watch out for those. best of luck with your exam.
passed my exam today. this is a good start to 2023.
great sharing
very helpful
thanks.. very helpful
i registered for 1z0-1047-23 but dumps qre available for 1z0-1047-22. help me with this...